デフォルト表紙
市場調査レポート
商品コード
1569464

緑内障手術用デバイスの市場規模、シェア、成長分析:製品別、手術方法別、最終用途別、地域別 - 産業予測、2024-2031年

Glaucoma Surgery Devices Market Size, Share, Growth Analysis, By Product, By Surgery Method, By End-use, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
緑内障手術用デバイスの市場規模、シェア、成長分析:製品別、手術方法別、最終用途別、地域別 - 産業予測、2024-2031年
出版日: 2024年10月08日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

緑内障手術用デバイスの世界市場規模は、2022年に14億米ドルと評価され、2023年の14億7,000万米ドルから2031年には21億2,000万米ドルに達し、予測期間(2024-2031年)のCAGRで4.70%の成長が予測されています。

緑内障手術用デバイス市場は、特に高齢化社会における緑内障の世界の罹患率の上昇を主な要因として、大きく成長しようとしています。この眼疾患の有病率が上昇するにつれて、効果的な外科的介入に対する需要も増加しており、成功率と安全性プロファイルを著しく改善した外科的技術の進歩に支えられています。低侵襲緑内障手術(MIGS)への顕著なシフトが観察されており、緑内障ドレナージシステムやレーザー装置のような装置は、合併症発生率の低下と患者の転帰の向上により人気を集めています。トラベキュラーマイクロバイパスステントや脈絡膜上シャントなどの技術を特徴とする低侵襲手術への動向は、白内障手術との複合的介入を容易にすると同時に回復期間の短縮を可能にし、市場に革命をもたらしています。緑内障の早期発見と早期介入の重要性に対する患者や医療プロバイダーの意識の高まりが、市場導入をさらに後押ししています。さらに、特に北米や欧州のような新興国市場では、有利な償還制度が市場の拡大を後押ししています。より良い手術結果を促進する患者中心の治療が重視される中、MIGSの採用は増加の一途をたどり、成長の極めて重要な原動力となっています。予測によると、米国の緑内障手術用デバイス市場は、今後の予測期間においても健全なCAGRを維持すると予測されており、この分野の将来性が強調されています。

目次

イントロダクション

  • 調査の目的
  • 定義
  • 市場範囲

調査手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模予測
  • 市場の想定と制限

エグゼクティブサマリー

  • 市場概要見通し
  • 供給需要動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主な市場の考察

  • 技術分析
  • バリューチェーン分析
  • 市場のエコシステム
  • ケーススタディ分析
  • 規制情勢
  • イノベーションマトリクス
  • 主な投資の分析
  • 主な成功要因
  • 競合の程度

緑内障手術用デバイス市場:製品別

  • 市場概要
  • 緑内障ドレナージデバイス
  • 従来型手術用デバイス
  • ダイヤモンドナイフ
  • レーザーシステム
  • その他

緑内障手術用デバイス市場:手術方法別

  • 市場概要
  • 従来型緑内障手術
  • 低侵襲緑内障手術
  • レーザー手術

緑内障手術用デバイス市場:最終用途別

  • 市場概要
  • 病院
  • 眼科クリニック
  • その他

緑内障手術用デバイス市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Alcon, Inc.(Switzerland)
  • Glaukos Corporation(US)
  • Johnson & Johnson Vision(US)
  • ASICO, LLC(US)
  • Carl Zeiss Meditec AG(Germany)
  • Ziemer Ophthalmic Systems AG(Switzerland)
  • Iridex Corporation(US)
  • Altomed(UK)
  • New World Medical, Inc.(US)
  • Ellex Medical Lasers Ltd.(Australia)
  • Topcon Corporation(Japan)
  • BVI Medical, Inc.(US)
  • MicroSurgical Technology(MST)(US)
  • Molteno Ophthalmic Ltd.(New Zealand)
  • OptoMedica Corporation(US)
  • iStar Medical SA(Belgium)
  • NeoMedix Corporation(US)
  • Sight Sciences, Inc.(US)
  • Aquesys, Inc.(US)
  • IOP Ophthalmics(US)
  • Katena Products, Inc.(US)
目次
Product Code: SQMIG35A2402

Global Glaucoma Surgery Devices Market size was valued at USD 1.40 billion in 2022 and is poised to grow from USD 1.47 billion in 2023 to USD 2.12 billion by 2031, growing at a CAGR of 4.70% during the forecast period (2024-2031).

The glaucoma surgery devices market is on the brink of significant growth, primarily fueled by the escalating global incidence of glaucoma, particularly among the aging population. As the prevalence of this eye condition rises, the demand for effective surgical interventions is also increasing, supported by advancements in surgical techniques that have markedly improved success rates and safety profiles. A notable shift toward minimally invasive glaucoma surgery (MIGS) has been observed, with devices like glaucoma drainage systems and laser equipment gaining popularity for their reduced complication rates and enhanced patient outcomes. The trend toward less invasive procedures, characterized by techniques such as trabecular micro-bypass stents and suprachoroidal shunts, is revolutionizing the market, allowing for shorter recovery periods while facilitating combined interventions with cataract surgeries. Increased awareness among patients and healthcare providers about the critical importance of early glaucoma detection and intervention further drives market adoption. Additionally, favorable reimbursement frameworks, especially in developed regions like North America and Europe, bolster market expansion. With a heightened emphasis on patient-centered care that promotes better surgical outcomes, the adoption of MIGS is set to continue its upward trajectory, making it a pivotal driver of growth. According to projections, the US glaucoma surgery devices market is anticipated to sustain a healthy compound annual growth rate (CAGR) in the upcoming forecast period, underscoring the promising future of this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the global glaucoma surgery devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global glaucoma surgery devices Market Segmental Analysis

Global Glaucoma Surgery Devices Market is segmented by Product, Surgery Method, End-use, and region. Based on Product, the market is segmented into Glaucoma Drainage Device, Traditional Surgery Devices, Diamond Knives, Laser Systems, and Others. Based on Surgery Method, the market is segmented into Traditional Glaucoma Surgery, Minimal Invasive Glaucoma Surgery, and Laser Surgery. Based on End-use, the market is segmented into Hospitals, Ophthalmic Clinics, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the global glaucoma surgery devices Market

The global glaucoma surgery devices market is significantly driven by the aging population and a rise in lifestyle-related factors, including prolonged screen time and an increase in diabetes prevalence, which contribute to a higher incidence of glaucoma. This escalating prevalence necessitates effective surgical interventions, thus intensifying the demand for advanced glaucoma surgery devices. Additionally, heightened awareness among healthcare providers and patients regarding the critical importance of early detection and timely treatment of glaucoma amplifies this market growth. As the healthcare landscape continues to evolve, the pressing need for innovative surgical solutions to combat glaucoma will further bolster the market's expansion.

Restraints in the global glaucoma surgery devices Market

The global glaucoma surgery devices market faces a significant restraint due to the high cost associated with surgical procedures. Factors including the necessity for advanced, specialized equipment, the requirement for highly skilled healthcare providers, and comprehensive post-operative care contribute to increased expenses. Additionally, the cost of the devices themselves adds to the financial burden, making glaucoma surgeries unaffordable for many patients, particularly in developing regions or among those lacking sufficient insurance coverage. This economic barrier not only restricts patient access to essential surgical interventions but also hampers the overall growth potential of the glaucoma surgery devices market.

Market Trends of the global glaucoma surgery devices Market

The global glaucoma surgery devices market is witnessing a significant trend towards combination therapies, which integrate various treatment modalities to optimize intraocular pressure (IOP) management. This approach enhances therapeutic outcomes by leveraging the synergistic effects of medications, laser treatments, and surgical techniques. The emergence of advanced glaucoma devices that incorporate drug-delivery systems, such as sustained-release implants, exemplifies this trend, allowing for targeted and controlled drug administration alongside surgical interventions. As healthcare providers increasingly adopt these innovative solutions, the market is positioned for robust growth, driven by the demand for more effective and personalized glaucoma treatment options.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Case study Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Glaucoma Surgery Devices Market by Product

  • Market Overview
  • Glaucoma Drainage Device
    • Valves
    • Glaucoma Drainage Implant
    • Glaucoma Tube Shunts
    • Stents
  • Traditional Surgery Devices
    • Scalpel
    • Forceps
    • Ophthalmic Scissors
    • Punch
    • Sutures
    • Surgical Drapes
    • Microcatheter
    • Others
  • Diamond Knives
  • Laser Systems
  • Others

Glaucoma Surgery Devices Market by Surgery Method

  • Market Overview
  • Traditional Glaucoma Surgery
    • Trabeculectomy
    • Tube Shunt Surgery
  • Minimal Invasive Glaucoma Surgery
    • Trabecular Meshwork Bypass
    • Suprachoroidal Space Implants
    • Subconjunctival Space Implants
    • Schlemm's Canal Implants
    • Gonioscopy-assisted Transluminal Trabeculectomy
    • Endocyclophotocoagulation
  • Laser Surgery
    • Trabeculoplasty
    • Iridotomy
    • Cyclophotocoagulation

Glaucoma Surgery Devices Market by End-use

  • Market Overview
  • Hospitals
  • Ophthalmic Clinics
  • Others

Glaucoma Surgery Devices Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Alcon, Inc. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Glaukos Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson Vision (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ASICO, LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Carl Zeiss Meditec AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ziemer Ophthalmic Systems AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Iridex Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Altomed (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • New World Medical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ellex Medical Lasers Ltd. (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Topcon Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BVI Medical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroSurgical Technology (MST) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molteno Ophthalmic Ltd. (New Zealand)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OptoMedica Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • iStar Medical SA (Belgium)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeoMedix Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sight Sciences, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aquesys, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IOP Ophthalmics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Katena Products, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments